Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.

Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D
J Clin Oncol. 2019 37 (22): 1946-1955

PMID: 31188726 · DOI:10.1200/JCO.19.00231

MeSH Terms (25)

Adult Aged Aged, 80 and over Bortezomib Cardiovascular Diseases Disease-Free Survival Electrocardiography Female Heart Diseases Humans Kaplan-Meier Estimate Male Middle Aged Molecular Targeted Therapy Multiple Myeloma Natriuretic Peptide, Brain Neoplasm Recurrence, Local Oligopeptides Prospective Studies Proteasome Inhibitors Risk Factors Time-to-Treatment Treatment Outcome Troponin I Troponin T

Connections (1)

This publication is referenced by other Labnodes entities: